EUVIMEDEUVIMED entdecken
Crossref

Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes

Baptiste Grenier, Isabelle Mosnier iD, Evelyne Ferrary iD, Yann Nguyen iD, Olivier Sterkers iD, Michel Kalamarides iD, Ghizlene Lahlou iD, Hannah Daoudi iD

Otolaryngology–Head and Neck Surgery · 2024

DOI: 10.1002/ohn.702 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Otolaryngology–Head and Neck Surgery, 2024. Verfasst von Baptiste Grenier und 7 weiteren Autor:innen. Beteiligte Einrichtung: ENT Department, La Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France. Hauptthemen laut MEDLINE: Neurofibromatosis 2, Cochlear Implantation, Neurofibromatoses. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate long‐term hearing outcomes following cochlear implantation in patients with neurofibromatosis type 2 and ipsilateral vestibular schwannoma. Study Design Retrospective study.

Setting

Tertiary general hospital.

Methods

Twenty‐two patients undergoing cochlear implantation between 2004 and 2018 with at least 1 year of follow‐up were included. Patients were categorized as “users” or “nonusers” of their cochlear implant (CI). For users, speech perception (disyllabic words) without lip‐reading was assessed in quiet conditions 1‐year postimplantation, and annually thereafter. CI users were classified into 2 groups on the basis of speech intelligibility (≥40% or

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neurofibromatosis 2Cochlear ImplantationNeurofibromatosesHumansMaleRetrospective StudiesFemaleMiddle AgedAdultSpeech PerceptionTreatment OutcomeSkin NeoplasmsAgedNeurilemmomaNeuroma, AcousticSpeech IntelligibilityFollow-Up Studies

Stichwörter der Autor:innen

NF2auditory outcomescochlear implanthearing rehabilitationvestibular schwannoma

Autor:innen und Institutionen

  • ENT Department, La Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
  • Technologies and Gene Therapy for Deafness, Hearing Institute, Pasteur Institute/Inserm /Université Paris Cité, Paris, France.
  • Neurosurgery Department, Pitié-Salpêtrière, APHP, Sorbonne University, Paris, France.
  • Genetics and Development of Brain Tumors, CRICM Inserm U1127 CNRS UMR 7225, Paris Brain Institute, Paris, France.

ORCID-Profile: Isabelle Mosnier, Evelyne Ferrary, Yann Nguyen, Olivier Sterkers, Michel Kalamarides, Ghizlene Lahlou, Hannah Daoudi

Zitieren

APA

Grenier, B., Mosnier, I., Ferrary, E., Nguyen, Y., Sterkers, O., Kalamarides, M., Lahlou, G., & Daoudi, H. (2024). Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes. Otolaryngology–Head and Neck Surgery. https://doi.org/10.1002/ohn.702

Vancouver

Grenier B, Mosnier I, Ferrary E, Nguyen Y, Sterkers O, Kalamarides M, et al. Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes. Otolaryngology–Head and Neck Surgery. 2024. doi:10.1002/ohn.702

BibTeX
@article{Grenier2024,
  author = {Grenier, Baptiste and Mosnier, Isabelle and Ferrary, Evelyne and Nguyen, Yann and Sterkers, Olivier and Kalamarides, Michel and Lahlou, Ghizlene and Daoudi, Hannah},
  title = {Cochlear Implantation in Neurofibromatosis Type 2‐Related Schwannomatosis: Long‐Term Hearing Outcomes},
  journal = {Otolaryngology–Head and Neck Surgery},
  year = {2024},
  doi = {10.1002/ohn.702}
}
Kostenlos starten →